277 related articles for article (PubMed ID: 821675)
1. Suppression of plasma renin activity by indomethacin in man.
Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
[TBL] [Abstract][Full Text] [Related]
2. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
[TBL] [Abstract][Full Text] [Related]
3. Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention.
Frölich JC; Hollifield JW; Michelakis AM; Vesper BS; Wilson JP; Shand DG; Seyberth HJ; Frölich WH; Oates JA
Circ Res; 1979 Jun; 44(6):781-7. PubMed ID: 218749
[TBL] [Abstract][Full Text] [Related]
4. The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man.
Speckart P; Zia P; Zipser R; Horton R
J Clin Endocrinol Metab; 1977 May; 44(5):832-7. PubMed ID: 870512
[TBL] [Abstract][Full Text] [Related]
5. The role of renal kallikrein and prostaglandin in the control of renin release.
Suzuki S; Kobayashi M; Hashiba K
Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
[TBL] [Abstract][Full Text] [Related]
6. The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension.
Ruilope L; Garcia Robles R; Barrientos A; Bernis C; Alcazar J; Tresguerres JA; Mancheño E; Millet VG; Sancho J; Rodicio JL
Clin Exp Hypertens A; 1982; 4(6):989-1000. PubMed ID: 7047008
[TBL] [Abstract][Full Text] [Related]
7. [Renin and aldosterone secretion under converting enzyme inhibition].
Nakamura K
Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1099-116. PubMed ID: 6141075
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man.
Patak RV; Mookerjee BK; Bentzel CJ; Hysert PE; Babej M; Lee JB
Prostaglandins; 1975 Oct; 10(4):649-59. PubMed ID: 1105697
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of renin--aldosterone and renal prostaglandin E during volume expansion induced by immersion in normal man.
Epstein M; Lifschitz MD; Re R; Haber E
Clin Sci (Lond); 1980 Jul; 59(1):55-62. PubMed ID: 7009025
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the mechanism of action of prostaglandin synthesis inhibitors on renin and aldosterone secretion and sodium excretion.
Papanicolaou N; Papadakis G; Papanicolaou P; Theodorakopoulos P; Paris M; Dontas A; Paris M; Bariety J; Milliez P
Prostaglandins Med; 1981 Aug; 7(2):163-81. PubMed ID: 6792644
[TBL] [Abstract][Full Text] [Related]
11. Reduction by indomethacin of furosemide effects in the rabbit.
Oliw E; Kövér G; Larsson C; Anggård E
Eur J Pharmacol; 1976 Jul; 38(1):95-100. PubMed ID: 954837
[TBL] [Abstract][Full Text] [Related]
12. Effects of indomethacin on plasma renin activity in the conscious rat.
Suzuki S; Franco-Saenz R; Tan SY; Mulrow PJ
Am J Physiol; 1981 Mar; 240(3):E286-9. PubMed ID: 7011052
[TBL] [Abstract][Full Text] [Related]
13. Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients.
Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Sato K; Imai Y; Sakurai Y; Ito T; Omata K; Yoshinaga K
Prostaglandins Med; 1980 Jul; 5(1):1-9. PubMed ID: 6996018
[TBL] [Abstract][Full Text] [Related]
14. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects.
Ichihara A; Suzuki H; Saruta T
J Lab Clin Med; 1993 Oct; 122(4):432-40. PubMed ID: 8228558
[TBL] [Abstract][Full Text] [Related]
15. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
[No Abstract] [Full Text] [Related]
16. Increase of free arachidonic acid by furosemide in man as the cause of prostaglandin and renin release.
Weber PC; Scherer B; Larsson C
Eur J Pharmacol; 1977 Feb; 41(3):329-32. PubMed ID: 837974
[TBL] [Abstract][Full Text] [Related]
17. Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.
Stichtenoth DO; Marhauer V; Tsikas D; Gutzki FM; Frölich JC
Kidney Int; 2005 Nov; 68(5):2197-207. PubMed ID: 16221219
[TBL] [Abstract][Full Text] [Related]
18. Effects of 1-Sar-8-Ile-angiotensin II on urinary prostaglandin excretion in patients with essential hypertension.
Yasujima M; Abe K; Otsuka Y; Chiba S; Ritsu K; Irokawa N; Seino M; Sakurai Y; Saito K; Ito T; Yoshinaga K
Tohoku J Exp Med; 1977 Nov; 123(3):271-8. PubMed ID: 601775
[TBL] [Abstract][Full Text] [Related]
19. Effect of selective inhibition of the inducible cyclooxygenase on renin release in healthy volunteers.
Stichtenoth DO; Wagner B; Frölich JC
J Investig Med; 1998 Aug; 46(6):290-6. PubMed ID: 9737091
[TBL] [Abstract][Full Text] [Related]
20. Effects of prostaglandin synthesis inhibition on blood pressure and humoral factors in exercising, sodium-deplete normal man.
Staessen J; Fagard R; Lijnen P; Moerman E; De Schaepdryver A; Amery A
J Hypertens; 1983 Aug; 1(2):123-30. PubMed ID: 6397516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
